These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29917150)

  • 1. Primary stroke prevention: a paradigm shift focusing on silent paroxysmal atrial fibrillation.
    Schattner A
    QJM; 2019 Apr; 112(4):247-249. PubMed ID: 29917150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.
    AlTurki A; Marafi M; Russo V; Proietti R; Essebag V
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptogenic stroke, atrial fibrillation and primary prevention.
    Schattner A; Hadad A
    Eur J Intern Med; 2014 Dec; 25(10):e124. PubMed ID: 25468252
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Kahwati LC; Yun JDY; Middleton JC; Coker-Schwimmer M; Asher GN
    JAMA; 2018 Aug; 320(5):485-498. PubMed ID: 30088015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
    Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
    Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to atrial fibrillation management: treat the patient, not the ECG.
    Pinter A; Dorian P
    Cardiovasc Ther; 2010 Oct; 28(5):302-10. PubMed ID: 20345495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective screening for atrial fibrillation using multivariable risk models.
    Linker DT; Murphy TB; Mokdad AH
    Heart; 2018 Sep; 104(18):1492-1499. PubMed ID: 29593077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions.
    Hyman DA; Siebert V; Jia X; Alam M; Levine GN; Virani SS; Birnbaum Y
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):105-117. PubMed ID: 30684116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland.
    Moran PS; Teljeur C; Harrington P; Smith SM; Smyth B; Harbison J; Normand C; Ryan M
    Value Health; 2016 Dec; 19(8):985-995. PubMed ID: 27987649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and management of atrial fibrillation in primary care.
    Ponamgi SP; Siontis KC; Rushlow DR; Graff-Radford J; Montori V; Noseworthy PA
    BMJ; 2021 Apr; 373():n379. PubMed ID: 33846159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Previously Unrecognized (Subclinical) Atrial Fibrillation.
    Kochav SM; Reiffel JA
    Am J Cardiol; 2020 Jul; 127():169-175. PubMed ID: 32423696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tactics of anticoagulant therapy in patients with cardiac implantable electronic devices and subclinical atrial fibrillation: A review].
    Razina TV; Serova MV; Andreev DA; Sazonova YS; Komarova AG
    Ter Arkh; 2023 May; 95(4):472054. PubMed ID: 38158984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical Atrial Fibrillation in Older Patients.
    Healey JS; Alings M; Ha A; Leong-Sit P; Birnie DH; de Graaf JJ; Freericks M; Verma A; Wang J; Leong D; Dokainish H; Philippon F; Barake W; McIntyre WF; Simek K; Hill MD; Mehta SR; Carlson M; Smeele F; Pandey AS; Connolly SJ;
    Circulation; 2017 Oct; 136(14):1276-1283. PubMed ID: 28778946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation.
    Marín F; Anguita-Sánchez M; Sanmartín M
    Expert Opin Pharmacother; 2017 Jan; 18(1):67-77. PubMed ID: 27924633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
    Wong CW
    Hong Kong Med J; 2016 Dec; 22(6):608-15. PubMed ID: 27920399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
    Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
    Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.
    Alkhouli M; Noseworthy PA; Rihal CS; Holmes DR
    J Am Coll Cardiol; 2018 Jun; 71(24):2790-2801. PubMed ID: 29903352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.
    Forslund T; Komen JJ; Andersen M; Wettermark B; von Euler M; Mantel-Teeuwisse AK; Braunschweig F; Hjemdahl P
    Stroke; 2018 Sep; 49(9):2122-2128. PubMed ID: 30354995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.